Firebrick starts Phase 3 common cold trial of Nasodine

• Phase 3 confirmatory trial of Nasodine for the common cold has started • Goal is to confirm Nasodine’s efficacy to support regulatory approval • Firebrick now has two major clinical trials underway, with results expected later this year ® the first patient has been recruited into its confirmatory Phase 3 trial for Nasodine Nasal Spray (“Nasodine”) as a treatment for the common cold. The randomis